CME vs MCO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 22, 2026

CME

37.7
AI Score
VS
MCO Wins

MCO

48.1
AI Score

Investment Advisor Scores

CME

38score
Recommendation
SELL

MCO

48score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CME MCO Winner
Revenue 4.26B 3.59B MCO
Net Income 1.54B 2.20B CME
Net Margin 36.1% 61.2% CME
Operating Income 1.97B 2.42B CME
ROE 50.9% 8.3% MCO
ROA 10.5% 1.1% MCO
Total Assets 14.68B 194.68B CME
Cash 1.47B 2.14B CME
Current Ratio 1.19 1.02 MCO
Free Cash Flow 1.53B 2.16B CME

Relative Price Performance (Last 90 Days)

CME 1M: +8.1% · 3M: -4.9% MCO 1M: +6.6% · 3M: +13.0%

Current Technical Phase

CME

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 65

RSI (14): 64.7 · Price: $274.98

MCO

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.2% over 20 days), RSI 63

RSI (14): 62.9 · Price: $503.32

Fundamentals Snapshot

Metric CME MCO
Market Cap
Forward P/E 21.3 26.6
Trailing P/E 22.6 31.5
Revenue (TTM)
Revenue Growth 0.0% 0.2%
Gross Margin 1.0% 0.7%
Operating Margin 0.7% 0.5%
EPS 11.97 15.81
Dividend Yield 0.02% 0.01%

Frequently Asked Questions

Based on our detailed analysis, MCO is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.